SHE:300639 Revenue

In the year 2025, Guangdong Hybribio Biotech had annual revenue of 669.64M CNY, down -17.89%. Guangdong Hybribio Biotech had revenue of 183.77M in the quarter ending December 31, 2025, a decrease of -10.48%.

Revenue

669.64M

Revenue Growth

-17.89%

P/S Ratio

5.75

Revenue / Employee

303.69K

Employees

2,205

Market Cap

3.85B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	669.64M	-145.89M	-17.89%
Dec 31, 2024	815.53M	-288.93M	-26.16%
Dec 31, 2023	1.10B	-4.49B	-80.27%
Jan 1, 2023	5.60B	2.92B	109.39%
Jan 1, 2022	2.67B	1.32B	97.34%
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Medicalsystem Biotechnology	1.54B
Shanghai Labway Clinical Laboratory	1.45B
Berry Genomics Co.,Ltd	929.82M
Thalys Medical Technology Group	971.32M
SMO ClinPlus CO.,LTD.	842.50M
Chemclin Diagnostics	332.68M
Shanghai Rendu Biotechnology	161.94M
Cowealth Medical China	656.38M

Revenue Rankings